Y Intercept (Hong Kong) LTD Omnicell, Inc Transaction History

Y Intercept (Hong Kong) LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$26.22 - $32.65 $510,162 - $635,271	19,457 New	19,457 $526,000
Q4 2022 Feb 14, 2023	BUY	$46.24 - $90.03 $432,575 - $842,230	9,355 New	9,355 $471,000
Q1 2022 May 16, 2022	SELL	$120.68 - $180.51 $276,115 - $413,006	-2,288 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$153.26 - $183.62 $350,658 - $420,122	2,288 New	2,288 $413,000
Q3 2021 Nov 15, 2021	SELL	$141.84 - $160.88 $324,246 - $367,771	-2,286 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$129.91 - $151.45 $296,974 - $346,214	2,286 New	2,286 $346,000
Q2 2021 Aug 12, 2021	SELL	$129.91 - $151.45 $232,798 - $271,398	-1,792 Closed	0 $346,000
Q1 2021 May 12, 2021	BUY	$117.78 - $143.9 $211,061 - $257,868	1,792 New	1,792 $231,000

277

44.6M

224K

35.7K

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $2.02B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.